InStar creates high value differentiated opportunities by:
- Developing product addressing unmet therapeutics needs
- Pursuing high technological barrier product
- Identifying unique repurposing opportunities
- Providing lifecycle management opportunities
Indication | R&D | in vitro/ex vivo | validation | prelinical | clinical | launch |
Migraines | ||||||
NSAID's | ||||||
Protein Diabetes | ||||||
Albumin | ||||||
Dietary supplement | ||||||
Erectile dysfunction | ||||||
Flavonoids |